#2FloEquityNews: There is promising news in the fight against sepsis— a life-threatening complication of an
#2FloEquity News: Two of our leaders, Paul Burton, JD, MBA and Sharon Ray, wrote this incredible and timely article
#2FloEquityNews: Angela L., COO and Executive Director of the 2Flo portfolio company 4DHealthware, recently attended National Association of
Join us in welcoming Dr. Modestus Obochi, PhD MBA to the 2Flo Ventures advisory committee and the
CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, announced on
2Flo Ventures recently attended the 2022 BIO International Convention with two of our portfolio companies.
Akan Biosciences, LLC (Akan), a Maryland based, clinical stage biotech company innovating cellular technology and proprietary
FORT WAYNE, Ind., Nov. 24, 2020 /PRNewswire/ — Vivacelle Bio, Inc. today announces the Department of Defense
The Chicago-based startup company plans to use the funding to further growth of its product
Temprian, a spinoff from Northwestern University, has a platform technology intended for the treatment of
Most COVID patients die of septic shock. In early studies VBI-S improved blood pressure and
Healthcare technology company, 4D Healthware, has joined the fight against the spread of the COVID-19
John founded Plowshares Asset Management LLC, with the primary focus of the development of multi-family residential real estate in the midwestern/western US. The firm has branched into healthcare via investments in private companies that seek to better the lives of others.
Prior to 1994 John was involved in various management/board positions with investment firms and partnerships ranging from sales/marketing to CFO/Treasurer/HR.
Chairman on the Board – First Congregational Church Evanston 1994-96
Board of Directors – Evanston Community Foundation 2015-2018
Volunteer – Martha’s Vineyard Food Bank 2020 – present
Sharon is the founder/CEO of S. Thompson & Associates, a consultancy that partners with Senior leadership teams to develop and optimize HR strategies and practices to help achieve their growth goals.
Sharon serves as Head of People and Operations at Cancer IQ, a genetic cancer risk assessment software firm. She has also served as the head of HR at Panopta, which was acquired in December 2020. Additionally, she served as Chief People Officer at Solstice.
Prior to that, Sharon served as Vice President of Human Resources for healthcare company Emmi Solutions, LLC. In that role, she built the human resources function, developing the HR infrastructure to provide strategic direction for the organization. During her 11.5 tenure, Sharon’s contributions resulted in Emmi Solutions’ acquisition by Wolters Kluwer for $170 million in 2016.
Previous roles include serving as Director of Innovation at Northwestern Medicine in Chicago; founder and Chairman of healthfinch; Chief Medical Officer and EVP of Product at MDLIVE; and founder/advisor to multiple other digital health companies over the years.
He currently sits on the board of Oneview Healthcare and is Editor-in-Chief for Telehealth and Medicine. He has served on multiple national boards in the past, including the Innovation Learning Network (ILN), the Association of Medical Directors of Information Systems (AMDIS) and the American Health Information Management Association (AHIMA) Foundation.
He has been listed as one of HealthLeader’s “Twenty People Who Make Healthcare Better”; Healthspottr’s “Future Health Top 100”, and Modern Healthcare’s “Top 25 Clinical Informaticists”.
He is an Associate Professor of Clinical Medicine at the Feinberg School of Medicine at Northwestern University. He has been elected to Fellowship in both the American College of Physicians (ACP) and the Healthcare Information Management Systems Society (HIMSS).
Since December 2018, Paul has been the CEO of Akan Biosciences, a biotech start-up developing regenerative medicinal therapeutics. Through Burton Advisory, he also advises early stage biotech as well as some digital healthcare companies such as Temprian Therapeutics, Schedule1, Cancer IQ, Care Advisors and 4D Healthware.
Additionally, Paul is currently an Entrepreneur In Residence at Northwestern University supporting students and faculty with healthcare oriented commercialization projects.
Previously, he was the CEO of ResQ Pharma, Inc. from July 2015 through December 2018. Similarly, he co-founded Vivacelle Bio, Inc. and was employed as its CFO and a member of its Board of Directors (BOD) from 2012 through 2015.
Paul is a Member of MATTER, a Chicago based healthcare incubator and the Bunker Labs, an Incubator started in Chicago for U.S. military veterans.
Paul started his professional career after law and business school as an investment banking associate at Salomon Brothers (now Citigroup Corporate & Investment Bank) in New York. Prior to grad school he served as a United States Regular Army Commissioned Officer (Infantry). While an undergraduate student Paul worked as a lab assistant at UIC’s Medical School Pharmacology Department, earning three co-authorships for research published in peer-reviewed journals.